Clinical trial
2-Hydroxybenzylamine: Multiple Dosing Study in Older Adults
NCT03556319 is registered in ClinicalTrials.gov with Metabolic Technologies Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 2-Hydroxybenzylamine: Multiple Dosing Study in Older Adults
- Lead sponsor
- Metabolic Technologies Inc.
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- May 23, 2018
- Completion date
- July 31, 2021
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
older adults